The granted Japan patent allows the Company to access an accelerated route-to-market for promising cellular medicines in Japan. This may significantly increase the value of cellular medicines as this enables a cheaper and faster route to market. #ROQ #siRNA #Cancer #Biotech

The Roquefort Therapeutics Board has the personal experience and a strong network from completing deals with Japan Big Pharma. We have initiated these discussions and will update the market in due course #ROQ #siRNA #Cancer #Biotech

Roquefort Therapeutics is pleased to announce its interim results for the six-month period ended 30 June 2024 londonstockexchange.com/news-article/R…

#ROQ is actively pursuing an out-licensing deal with Big Pharma for its STAT-6 siRNA programme #ROQ believes that positive immunology results will enhance the existing positive oncology results & therefore strengthen the programme's attractiveness to potential licensees

Back in 2014, Novartis ditched its RNAi research, giving the lead scientist the first "courage award" for stopping bad projects!🤦‍♂️ Novartis ex-CEO Joseph Jimenez said at the time, "One of the reasons why spending in the pharmaceutical industry is so high is that many scientists

🎥 Our CEO Ajan Reginald with Steve Darling from @proactive_UK on the promising results of our STAT-6 siRNA program #ROQ #Cancer #siRNA youtube.com/watch?v=716uRX…

Roquefort Therapeutics - STAT-6 siRNA Presentation at Advanced Therapy Development Congress #ROQ #siRNA #STAT6 londonstockexchange.com/news-article/R…

$ROQ Roquefort presentation reveals the biotech is a leader in emerging targeted treatment field tinyurl.com/22qg2e88 Roquefort Therapeutics $ROQAF #ROQ #ROQAF

We are progressing with the Company's near-term imperative, which remains, to complete meaningful partnerships with one or more Big Pharma companies #ROQ #siRNA #STAT6

⁦⁦⁦Roquefort Therapeutics⁩ RNS re: sale of Lyramid subsidiary #ROQ proactiveinvestors.co.uk/companies/news…

🎥 Our CEO Ajan Reginald talks with Stephen Gunnion from @proactive_UK on the transformational proposed sale of our Midkine portfolio to Pleiades Pharma Ltd #ROQ #Midkine #biotech youtu.be/siSIreDVYmc

$10m Pleiades deal signed. Details in RNS and Proactive interview to follow roquefortplc.com/regulatory-new…

Roquefort looks to the future as it inks Lyramid sale agreement Roquefort Therapeutics #LSE #ROQ ow.ly/6r4T105YzwJ

Roquefort Therapeutics CEO Ajan Reginald on strategic asset sale to Pleiades Pharma Roquefort Therapeutics #LSE #ROQ ow.ly/GLCR105YAEq

Daily Mail story on #ROQ linkedin.com/posts/roquefor…

'Talent is everywhere, but opportunity is not. Except at Oxford.' VC Prof Irene Tracey shares what she wants the University to be remembered for. Read the Vice-Chancellor’s Oration in full ⬇️

Great discussion at this 2025 Evolution conference on innovation in BioPharma linkedin.com/posts/myrto-an…

Varsity (Ivy League) athletes earn 3.4% more over their entire careers, and attain more senior positions than their classmates despite entering college with lower academic qualifications

Scientists have uncovered how #leukaemia cells “cheat death”; rewiring their mitochondria to evade one of today’s most effective treatments. The discovery could lead to new ways to defeat drug-resistant leukemia. #TCSC #Leukemia #Oncology #Cancer #Cells scitechdaily.com/scientists-dis…